雷公藤甲素
生物利用度
化学
体内
肝细胞癌
溶解度
环糊精
体外
核化学
药理学
癌症研究
色谱法
生物化学
医学
有机化学
细胞凋亡
生物技术
生物
作者
Zhe Li,Gang Yang,Rong Wang,Yuanyuan Wang,Jing Wang,Meng Yang,Chunai Gong,Yongfang Yuan
标识
DOI:10.1007/s13346-021-00978-7
摘要
Abstract Triptolide (TPL) has been employed to treat hepatocellular carcinoma (HCC). However, the poor water-solubility of TPL restrict its applications. Therefore, we prepared TPL loaded cyclodextrin-based metal-organic framework (TPL@CD-MOF) to improve the solubility and bioavailability of TPL, thus enhancing the anti-tumor effect on HCC. The BET surface and the pore size of TPL@CD-MOF were 1134.5 m2·g−1 and 1.6 nm, respectively. The results of XRD indicated that TPL in TPL@CD-MOF was encapsuled. TPL@CD-MOF showed a slower release than free TPL in vitro. Moreover, the CD-MOF improved the cell internalization and bioavailability of TPL. TPL@CD-MOF also showed higher anti-tumor efficacy in vitro and in vivo compared to free TPL. As a carrier, CD-MOF improved the solubility and bioavailability of TPL. In addition, TPL@CD-MOF exhibited improved anti-tumor effects in vitro and in vivo, indicating great potential as a carrier for insoluble anti-tumor drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI